You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Johnson and Johnson

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018716

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 018716 describes TRANDATE, which is a drug marketed by Sebela Ireland Ltd, Cnty Line Pharms, and Glaxosmithkline, and is included in three NDAs. It is available from four suppliers. Additional details are available on the TRANDATE profile page.

The generic ingredient in TRANDATE is hydrochlorothiazide; labetalol hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; labetalol hydrochloride profile page.
Summary for 018716
Applicant:Cnty Line Pharms
Ingredient:labetalol hydrochloride
Formulation / Manufacturing:see details
Pharmacology for NDA: 018716
Mechanism of ActionAdrenergic beta-Antagonists
Suppliers and Packaging for NDA: 018716
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRANDATE labetalol hydrochloride TABLET;ORAL 018716 NDA County Line Pharmaceuticals LLC 43199-037 43199-037-01 100 TABLET in 1 BOTTLE (43199-037-01)
TRANDATE labetalol hydrochloride TABLET;ORAL 018716 NDA County Line Pharmaceuticals LLC 43199-037 43199-037-05 500 TABLET in 1 BOTTLE (43199-037-05)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:May 24, 1985TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength200MG
Approval Date:Aug 1, 1984TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength300MG
Approval Date:Aug 1, 1984TE:ABRLD:Yes

Expired US Patents for NDA 018716

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.